Our in vitro experiments showed that silencing INHBA suppressed the growth of CRC cells by arresting the cell cycle in the G1 phase, whereas overexpression of INHBA resulted in an opposite effect. The gene discussed is INHBA; the disease is colorectal carcinoma.